Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Granulocytic Leukemia

1-methyl-3-isobutylxanthine has been researched along with Granulocytic Leukemia in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamaguchi, M1
Hirayoshi, K1
Okuma, M1
Nagata, K1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Granulocytic Leukemia

ArticleYear
Enhancement of differentiation induction of mouse myelomonocytic leukemic cells by extracellular ATP.
    Journal of cellular physiology, 1994, Volume: 159, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Actins; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Aden

1994